KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer.
Cell death & disease
Yao H, Ren D, Wang Y, Wu L, Wu Y, Wang W, Li Q, Liu L.
Publication Overview
Key findings, Countstar context, and access to the original paper.
2022
Cancer Research
No items found.
Key Finding
However, the molecular mechanisms underlying CRC progression remain to be further defined to improve patient outcomes. Survival analysis showed that patients whose tumors expressed low KCTD9 levels had poorer outcomes.
Countstar Connection
Within the study, Countstar (model not specified) measured cell numbers during growth assessment in the study's cell samples during the study's migration assessment.
